Relation of mucous membrane alterations to oral intake during the first year after treatment for head and neck cancer

Head and Neck

Volumn 33, Issue 6, 2011, Pages 774-779

  Pauloski, Barbara Roa ^a   Rademaker, Alfred W ^b   Logemann, Jerilyn A ^a   Lundy, Donna ^c   Bernstein, Michelle ^c   McBreen, Carrie ^a,h   Santa, Daphne ^d   Campanelli, Angela ^e   Kelchner, Lisa ^f   Klaben, Bernice ^g,i   Discekici Harris, Muveddet ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e KETTERING MEDICAL CENTER   (United States)

^f UNIVERSITY OF CINCINNATI   (United States)

^g Blaine Block Institute for Voice Analysis and Rehabilitation   (United States)

^h JESSE BROWN VA MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF CINCINNATI   (United States)

Author keywords

chemotherapy; diet; head and neck cancer; mucositis; oral intake; radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; DYSPHAGIA; EATING; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; MUCOSA INFLAMMATION; PAIN ASSESSMENT; PRIORITY JOURNAL;

ADULT; AFTERCARE; AGED; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COMBINED MODALITY THERAPY; DEGLUTITION; DEGLUTITION DISORDERS; DIET; EATING; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; MUCOSITIS; NECK DISSECTION; NEOPLASM STAGING; PAIN; PAIN MEASUREMENT; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79955917290     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21542     Document Type: Article

References (42)

1. Spijkervet FK, van Saene HK, Panders AK, Vermey A, Mehta DM,. Scoring irradiation mucositis in head and neck cancer patients. J Oral Pathol Med 1989; 18: 167-171. (Pubitemid 19173581)
2. Lalla RV, Peterson DE,. Treatment of mucositis, including new medications. Cancer J 2006; 12: 348-354. (Pubitemid 44564818)
3. Trotti A, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003; 66: 253-262. (Pubitemid 36556043)
4. Stokman MA, Spijkervet FK, Boezen HM, Schouten JP, Roodenburg JL, de Vries EG,. Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses. J Dent Res 2006; 85: 690-700. (Pubitemid 44297322)
5. Mantini G, Manfrida S, Cellini F, et al. Impact of dose and volume on radiation-induced mucositis. Rays 2005; 30: 137-144. (Pubitemid 41606285)
6. van den Broek GB, Balm AJ, van den Brekel MW, Hauptmann M, Schornagel JH, Rasch CR,. Relationship between clinical factors and the incidence of toxicity after intra-arterial chemoradiation for head and neck cancer. Radiother Oncol 2006; 81: 143-150. (Pubitemid 44780781)
7. Denham JW, Peters LJ, Johansen J, et al. Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer? Radiother Oncol 1999; 52: 157-164. (Pubitemid 29461083)
8. Palazzi M, Tomatis S, Orlandi E, et al. Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system. Int J Radiat Oncol Biol Phys 2008; 70: 330-337.
9. Wygoda A, Maciejewski B, Skladowski K, et al. Pattern analysis of acute mucosal reactions in patients with head and neck cancer treated with conventional and accelerated irradiation. Int J Radiat Oncol Biol Phys 2009; 73: 384-390.
10. Stokman MA, Spijkervet FK, Wymenga AN, et al. Quantification of oral mucositis due to radiotherapy by determining viability and maturation of epithelial cells. J Oral Pathol Med 2002; 31: 153-157. (Pubitemid 34432221)
11. Sonis ST, Eilers JP, Epstein JB, et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer 1999; 85: 2103-2113. (Pubitemid 29215547)
12. Shah N, Saunders MI, Dische S,. A pilot study of postoperative CHART and CHARTWEL in head and neck cancer. Clin Oncol (R Coll Radiol) 2000; 12: 392-396. (Pubitemid 32051524)
13. Allal AS, Monney M, Rosset A, Ozsahin M, Guillemin C,. An original accelerated radiotherapy schedule in stage III to IV head and neck cancers. Results in a multicenter setting. Strahlenther Onkol 2000; 176: 28-31. (Pubitemid 30035903)
14. Bentzen SM, Saunders MI, Dische S, Bond SJ,. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol 2001; 60: 123-135. (Pubitemid 32601965)
15. Sunwoo JB, Herscher LL, Kroog GS, et al. Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer. J Clin Oncol 2001; 19: 800-811. (Pubitemid 32119096)
16. Mekhail TM, Adelstein DJ, Rybicki LA, Larto MA, Saxton JP, Lavertu P,. Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube? Cancer 2001; 91: 1785-1790. (Pubitemid 32377965)
17. Penpattanagul S,. Reduced incidence and severity of acute radiation mucositis by WF10 (IMMUNOKINE) as adjunct to standard of cure in the management of head & neck cancer patients. J Med Assoc Thai 2007; 90: 1590-1600. (Pubitemid 47414481)
18. de Castro G Jr, Snitcovsky IM, Gebrim EM, et al. High-dose cisplatin concurrent to conventionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2007; 264: 1475-1482. (Pubitemid 350112409)
19. Allal AS, Zwahlen D, Becker M, Dulguerov P, Mach N,. Phase I trial of concomitant hyperfractionated radiotherapy with docetaxel and cisplatin for locally advanced head and neck cancer. Cancer J 2006; 12: 63-68.
20. Nguyen NP, North D, Smith HJ, et al. Safety and effectiveness of prophylactic gastrostomy tubes for head and neck cancer patients undergoing chemoradiation. Surg Oncol 2006; 15: 199-203. (Pubitemid 46771192)
21. Nguyen NP, Vos P, Smith HJ, et al. Concurrent chemoradiation for locally advanced oropharyngeal cancer. Am J Otolaryngol 2007; 28: 3-8. (Pubitemid 44879644)
22. Guerrero Urbano T, Clark CH, Hansen VN, et al. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer. Radiother Oncol 2007; 85: 36-41. (Pubitemid 47570062)
23. Anand AK, Chaudhoory AR, Shukla A, et al. Favourable impact of intensity-modulated radiation therapy on chronic dysphagia in patients with head and neck cancer. Br J Radiol 2008; 81: 865-871.
24. Hutcheson KA, Barringer DA, Rosenthal DI, May AH, Roberts DB, Lewin JA,. Swallowing outcomes after radiotherapy for laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 2008; 134: 178-183. (Pubitemid 351287499)
25. Adelstein DJ, Saxton JP, Lavertu P, et al. Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiation and concurrent chemotherapy. J Clin Oncol 2002; 20: 1405-1410. (Pubitemid 34177449)
26. Psyrri A, Kwong M, DiStasio S, et al. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. J Clin Oncol 2004; 22: 3061-3069. (Pubitemid 41103718)
27. Kin-Fong Cheng K, Ka Tsui Yuen J,. A pilot study of chlorhexidine and benzydamine oral rinses for the prevention and treatment of irradiation mucositis in patients with head and neck cancer. Cancer Nurs 2006; 29: 423-430. (Pubitemid 44483999)
28. Cella D, Pulliam J, Fuchs H, et al. Evaluation of pain associated with oral mucositis during the acute period after administration of high-dose chemotherapy. Cancer 2003; 98: 406-412. (Pubitemid 36828468)
29. Silverman S Jr,. Diagnosis and management of oral mucositis. J Support Oncol 2007; 5 (2 Suppl 1): 13-21. (Pubitemid 46344213)
30. Sonis ST,. The pathobiology of mucositis. Nat Rev Cancer 2004; 4: 277-284. (Pubitemid 38525283)
31. Rubira CM, Devides NJ, Ubeda LT, et al. Evaluation of some oral postradiotherapy sequelae in patients treated for head and neck tumors. Braz Oral Res 2007; 21: 272-277.
32. Dietz A, Nollert J, Maier H, Rudat V, Flentje M,. The problem of radiogenic and chemotherapy-induced mucositis of the mouth and oropharynx exemplified by accelerated radiochemotherapy with carboplatin in patients with inoperable squamous epithelial carcinoma of the head-/neck area. Heidelberg experiences. [Article in German] HNO 1995; 43: 403-413.
33. Lazarus CL,. Effects of radiation therapy and voluntary maneuvers on swallow functioning in head and neck cancer patients. Clin Commun Disord 1993; 3: 11-20.
34. Dworkin JP, Hill SL, Stachler RJ, Meleca RJ, Kewson D,. Swallowing function outcomes following nonsurgical therapy for advanced-stage laryngeal carcinoma. Dysphagia 2006; 21: 66-74. (Pubitemid 43926938)
35. Jensen K, Lambertsen K, Grau C,. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters. Radiother Oncol 2007; 85: 74-82. (Pubitemid 47562582)
36. Hughes PJ, Scott PM, Kew J, et al. Dysphagia in treated nasopharyngeal cancer. Head Neck 2000; 22: 393-397. (Pubitemid 30413306)
37. Chang YC, Chen SY, Lui LT, et al. Dysphagia in patients with nasopharyngeal cancer after radiation therapy: a videofluoroscopic swallowing study. Dysphagia 2003; 18: 135-143. (Pubitemid 36918090)
38. Wu CH, Hsiao TY, Ko JY, Hsu MM,. Dysphagia after radiotherapy: endoscopic examination of swallowing in patients with nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 2000; 109: 320-325.
39. Bleier BS, Levine MS, Mick R, et al. Dysphagia after chemoradiation: analysis by modified barium swallow. Ann Otol Rhinol Laryngol 2007; 116: 837-841. (Pubitemid 350174843)
40. Kohler PF, Winter ME,. A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum 1985; 28: 1128-1132. (Pubitemid 16250648)
41. List MA, Ritter-Sterr C, Lansky SB,. A performance status scale for head and neck cancer patients. Cancer 1990; 66: 564-569. (Pubitemid 20233457)
42. Logemann JA, Pauloski BR, Rademaker AW, et al. Xerostomia: 12-month changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation. Head Neck 2003; 25: 432-437. (Pubitemid 36577026)